In this next article in our series on research ethics, Anant Bhan, bioethicist and global health & policy researcher, speaks to IndiaBioscience about the landscape of clinical trial malpractice in India and the need for pharmacovigilance, which is the science of monitoring, evaluating and understanding adverse effects associated with drugs and medical devices even after they have been released into the mass market.
Academician-turned-entrepreneur Priyangshu Manab Sarma speaks about his experience in tapping research leads generated in Indian labs to develop technologies to serve India's indigenous needs in a scalable and economically viable manner.
Dipyaman Ganguly is an immunologist and currently a senior scientist at the Indian Institute of Chemical Biology (IICB), Kolkata. In this interview with IndiaBioscience, he talks about how public science outreach efforts in India need to expand beyond already engaged audiences in big cities and towns and make forays into remote geographical locations to reach children and adults who lack previous scientific exposure.
Shubha Tole is a Professor of Neurobiology at Tata Institute of Fundamental Research. She spoke to IndiaBioscience about her research and her interest in science outreach.
The European Molecular Biology Organisation has inducted Arun Shukla as one of the researchers in its Young Investigators Program, 2017. He talks to IndiaBioscience about the award and the research opportunities that it opens up.